Publications by authors named "Saud Alsifri"

Claim this Profile
E
Expert Opinion Statement on Continuous Glucose Monitoring in Type 2 Diabetes in the Arab Gulf Region.
Abdulrahman Alshaikh, Abdulmohsen Bakhsh, Afaf Al-Sagheir, Ahmed El-Laboudi, Dabia Al-Mohanadi, Saud Alsifri

J Diabetes Sci Technol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a Comprehensive Approach for Managing Cardiorenal Metabolic Diseases (CRMD) in Saudi Arabia: Thinking beyond Single Disease-Literature Review and Multidisciplinary Consensus Report.
Abdulrahman Alshaikh, Ali Alshehri, Lamya Alzubaidi, Hussein Elbadawi, Abdulghani Alsaeed, Saud Alsifri

Diabetes Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saudi Clinical Practice Guidelines for management of diabetic kidney disease in adults.
Khalid I Almatham, Hajer Y Almudaiheem, Waleed A Alhazzani, Haifa F Alotaibi, Saad S Alobaili, Saud N Alsifri

Saudi Med J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic dysfunction-associated steatotic liver disease management in Saudi Arabia: A modified Delphi-based adaptation of international standards.
Faisal Abaalkhail, Faisal M Sanai, Khalid AlSwat, Adnan Alzanbagi, Ahmed Aljedai, Saud Alsifri

Saudi J Gastroenterol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Saudi Heart Association Position Statement on Cardiovascular Diseases and Diabetes Mellitus.
Waleed Alhabeeb, Abdelfatah Elasfar, Abdulhalim J Kinsara, Ahmed Aljizeeri, Ibrahim Jelaidan, Saud Alsifri

J Saudi Heart Assoc· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Saudi Heart Association Position Statement on Obesity and Cardiovascular Disease.
Waleed Alhabeeb, Abdulhalim J Kinsara, Abeer Bakhsh, Adel Tash, Afaf Alshammary, Saud Alsifri

J Saudi Heart Assoc· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of iGlarLixi in adults with type 2 diabetes mellitus from Gulf countries during Ramadan holy month: A subgroup analysis of the SoliRam observational study.
Mohamed Hassanein, Adel El Naggar, Abdulrahman Al Sheikh, Khier Djaballah, Mohamed Saeed, Saud AlSifri

Diabetes Res Clin Pract· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Clinical Effectiveness and Safety of Semaglutide in Individuals with Uncontrolled Type 2 Diabetes. Real-World Evidence from Saudi Arabia: The Observational, Multicenter, 15-Month EVOLUTION Study.
Abdulrahman Alsheikh, Ali Alshehri, Saad Alzahrani, Anwar A Jammah, Fahad Alqahtani, Saud Alsifri

Diabetes Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Who Fast During Ramadan in The Gulf Region: A Subgroup Analysis of the Real-World ORION Study.
Rayaz A Malik, Tarik Elhadd, Abdulnabi Alattar, Abdulrahman Al Shaikh, Muneera Al Randi

Diabetes Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas.
Yousef Al-Saleh, Shaun Sabico, Ahmed Al-Furqani, Amin Jayyousi, Dalal Alromaihi

Diabetes Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas.
Yousef Al-Saleh, Shaun Sabico, Ahmed Al-Furqani, Amin Jayyousi, Dalal Alromaihi

Diabetes Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real-world studies.
Ulrik Pedersen-Bjergaard, Saud Alsifri, Ronnie Aronson, Maja Cigrovski Berković, Gagik Galstyan

Diabetes Obes Metab· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes.
Kamlesh Khunti, Saud Alsifri, Ronnie Aronson, Maja Cigrovski Berković, Catherine Enters-Weijnen

Diabetes Res Clin Pract· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dyslipidaemia in the Middle East: Current status and a call for action.
Khalid Al Rasadi, Wael Almahmeed, Khalid F AlHabib, Marianne Abifadel, Hasan Ali Farhan, Saud AlSifri

Atherosclerosis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach.
Jean Claude Mbanya, Saud Al-Sifri, Aly Abdel-Rahim, Ilhan Satman

Diabetes Res Clin Pract· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic neurohypophysial diabetes insipidus: reversibility of structural and functional renal abnormalities after treatment.
Saud N Alsifri, Haroon A Faraz, Yusuf Al Kadhi, Mohammed Ahmed, Abdulraof A Almahfouz

Endocr Pract· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis